Skip to main content
. 2021 Jan 14;16(8):990–994. doi: 10.1177/1747493020984073

Table 1.

Examinations at baseline and follow-up

Days
Months
1
2
7 a
3
Time 1 b Time 2 c 30 min 1 h 3 h
Non-contrast CT x x x
CT angiography (x) x (x)
CT perfusion (x) (x)
NIHSS x x x
BP monitoring x x x x x x
mRS x x x
Centralized telephone interview x

Note: Day 1 is the day of entry into the trial.

a

Day 7 or day of discharge, whichever occurs first.

b

Time 1: at randomization.

c

Time 2: at time of intervention/treatment.

BP: blood pressure; NIHSS: National Institutes of Health Stroke Scale; mRS: modified Rankin Scale; (x): optional examination which should not influence the decision to include the patient, unless the results of the examination, according to the judgment of the investigator, show that the patient should or should not receive thrombolytic treatment.